U.S. Immunoglobulin Market Size, Share & Industry Analysis, By Product Type (Intravenous Immunoglobulin (IVIG) {Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Immune Thrombocytopenic Purpura, Multifocal Motor Neuropathy, and Others}, and Subcutaneous Immunoglobulin (SCIG) {Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, and Others}), By Form (Liquid and Lyophilized), By End User (Hospitals, Clinics, and Homecare), and Country Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI108226

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 7.89% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Product Type, Form, End User, and Region
By Product Type	· Intravenous Immunoglobulin (IVIG) o Primary Immunodeficiency o Secondary Immunodeficiency o Chronic Inflammatory Demyelinating Polyneuropathy o Guillain-Barré Syndrome o Immune Thrombocytopenic Purpura o Multifocal Motor Neuropathy o Others · Subcutaneous Immunoglobulin (SCIG) o Primary Immunodeficiency o Secondary Immunodeficiency o Chronic Inflammatory Demyelinating Polyneuropathy o Others
By Form	· Liquid · Lyophilized
By End User	· Hospitals · Clinics · Homecare